| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant activity of interferon alpha: mechanism(s) of action
|
Tovey, Michael G.
|
|
2006
|
24 |
S2 |
p. S46-S47
2 p.
|
artikel
|
| 2 |
Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid
|
Balboa, Julio A.
|
|
2006
|
24 |
S2 |
p. S63-S64
2 p.
|
artikel
|
| 3 |
Adjuvants: Present regulatory challenges
|
Pascual, Danay Mora
|
|
2006
|
24 |
S2 |
p. S88-S89
2 p.
|
artikel
|
| 4 |
A novel adjuvant complex, tyrosine-MPL, for prophylactic and therapeutic vaccines
|
Wheeler, Alan
|
|
2006
|
24 |
S2 |
p. S40-S41
2 p.
|
artikel
|
| 5 |
Antibodies against cell surface antigens as very potent immunological adjuvants
|
Barr, Tom
|
|
2006
|
24 |
S2 |
p. S20-S21
2 p.
|
artikel
|
| 6 |
Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation
|
Mielcarek, Nathalie
|
|
2006
|
24 |
S2 |
p. S54-S55
2 p.
|
artikel
|
| 7 |
Bacterial derived proteoliposome as ideal delivery system and cellular adjuvant
|
Rodríguez, Tamara
|
|
2006
|
24 |
S2 |
p. S24-S25
2 p.
|
artikel
|
| 8 |
Bacterial derived proteoliposome for allergy vaccines
|
Lastre, Miriam
|
|
2006
|
24 |
S2 |
p. S34-S35
2 p.
|
artikel
|
| 9 |
Comparative study of the immunogenicity and immunoenhancing effects of two hepatitis B core antigen variants in mice by nasal administration
|
Lobaina, Y.
|
|
2006
|
24 |
S2 |
p. S58-S59
2 p.
|
artikel
|
| 10 |
CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and tactics
|
Harandi, Ali M.
|
|
2006
|
24 |
S2 |
p. S48-S49
2 p.
|
artikel
|
| 11 |
Editorial Board/Aims and Scope
|
|
|
2006
|
24 |
S2 |
p. CO2-
1 p.
|
artikel
|
| 12 |
High-performance reverse phase chromatography with fluorescence detection assay for characterization and quantification of pneumococcal polysaccharides
|
Canaán-Haden, Leonardo
|
|
2006
|
24 |
S2 |
p. S70-S71
2 p.
|
artikel
|
| 13 |
How bacteria and their products provide clues to vaccine and adjuvant development
|
Dougan, Gordon
|
|
2006
|
24 |
S2 |
p. S13-S19
7 p.
|
artikel
|
| 14 |
IFN-α/β-dependent cross-priming induced by specific toll-like receptor agonists
|
Durand, Vanessa
|
|
2006
|
24 |
S2 |
p. S22-S23
2 p.
|
artikel
|
| 15 |
Immunological evaluation of bacterial derived Cochleate and Proteoliposome as mucosal adjuvants
|
del Campo, Judith
|
|
2006
|
24 |
S2 |
p. S50-S51
2 p.
|
artikel
|
| 16 |
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
|
Black, Steven
|
|
2006
|
24 |
S2 |
p. S79-S80
2 p.
|
artikel
|
| 17 |
Invitation to next meeting
|
|
|
2006
|
24 |
S2 |
p. III-
1 p.
|
artikel
|
| 18 |
Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants
|
Turánek, Jaroslav
|
|
2006
|
24 |
S2 |
p. S90-S91
2 p.
|
artikel
|
| 19 |
Modulation of the specific allergic response by mite allergens encapsulated into liposomes
|
Calderón, Lesly
|
|
2006
|
24 |
S2 |
p. S38-S39
2 p.
|
artikel
|
| 20 |
Mucosal immune responses to meningococcal C polysaccharide–protein conjugate in mice
|
Cuello, Maribel
|
|
2006
|
24 |
S2 |
p. S72-S73
2 p.
|
artikel
|
| 21 |
2nd International Workshop on Vaccine Adjuvants and Glycoconjugates, Varadero, Cuba, 11–15 April 2004
|
Pérez, Oliver
|
|
2006
|
24 |
S2 |
p. S1-S2
2 p.
|
artikel
|
| 22 |
New method for obtaining conjugated vaccines
|
Cabrera, Osmir
|
|
2006
|
24 |
S2 |
p. S76-S78
3 p.
|
artikel
|
| 23 |
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
|
Petrovsky, Nikolai
|
|
2006
|
24 |
S2 |
p. S26-S29
4 p.
|
artikel
|
| 24 |
On the cross-fertilization between biotechnology and immunology: current situation in Cuba
|
Lage, Agustin
|
|
2006
|
24 |
S2 |
p. S3-S6
4 p.
|
artikel
|
| 25 |
Poster abstract
|
|
|
2006
|
24 |
S2 |
p. S96-S102
7 p.
|
artikel
|
| 26 |
Preparation and evaluation of Vibrio cholerae O1 EL Tor Ogawa lipopolysaccharide–tetanus toxoid conjugates
|
Cabrera, Osmir
|
|
2006
|
24 |
S2 |
p. S74-S75
2 p.
|
artikel
|
| 27 |
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine
|
Pérez, Oliver
|
|
2006
|
24 |
S2 |
p. S52-S53
2 p.
|
artikel
|
| 28 |
Proteoliposome derived cochleate as novel adjuvant
|
Bracho, Gustavo
|
|
2006
|
24 |
S2 |
p. S30-S31
2 p.
|
artikel
|
| 29 |
Regulatory considerations on new adjuvants and delivery systems
|
Sesardic, D.
|
|
2006
|
24 |
S2 |
p. S86-S87
2 p.
|
artikel
|
| 30 |
Reverse vaccinology — In search of a genome-derived meningococcal vaccine
|
Danzig, Lisa
|
|
2006
|
24 |
S2 |
p. S11-S12
2 p.
|
artikel
|
| 31 |
Scale up of proteoliposome derived Cochleate production
|
Zayas, Caridad
|
|
2006
|
24 |
S2 |
p. S94-S95
2 p.
|
artikel
|
| 32 |
State of the art in developing allergen vaccines in Cuba: prospects of novel adjuvanted vaccines
|
Labrada, Alexis
|
|
2006
|
24 |
S2 |
p. S36-S37
2 p.
|
artikel
|
| 33 |
Strategy for determination of an efficient Cochleate particle size
|
Gil, Danay
|
|
2006
|
24 |
S2 |
p. S92-S93
2 p.
|
artikel
|
| 34 |
Sucrose fatty acid sulphate esters as novel vaccine adjuvant
|
Hilgers, Luuk A.Th.
|
|
2006
|
24 |
S2 |
p. S81-S82
2 p.
|
artikel
|
| 35 |
Surfactants in vaccine adjuvants: description and perspectives
|
Ascarateil, Stephane
|
|
2006
|
24 |
S2 |
p. S83-S85
3 p.
|
artikel
|
| 36 |
The adjuvant potential of synthetic alkylglycerols
|
Acevedo, Reinaldo
|
|
2006
|
24 |
S2 |
p. S32-S33
2 p.
|
artikel
|
| 37 |
The use of oil adjuvants in therapeutic vaccines
|
Aucouturier, Jerome
|
|
2006
|
24 |
S2 |
p. S44-S45
2 p.
|
artikel
|
| 38 |
The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery
|
Davis, Stanley S.
|
|
2006
|
24 |
S2 |
p. S7-S10
4 p.
|
artikel
|
| 39 |
Transepithelial immunomodulation by cholera toxin and non-toxic derivatives
|
Anjuère, Fabienne
|
|
2006
|
24 |
S2 |
p. S62-
1 p.
|
artikel
|
| 40 |
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus
|
Bracci, Laura
|
|
2006
|
24 |
S2 |
p. S56-S57
2 p.
|
artikel
|
| 41 |
Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: Is an additional vaccine needed or possible?
|
Shinefield, Henry R.
|
|
2006
|
24 |
S2 |
p. S65-S69
5 p.
|
artikel
|
| 42 |
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for dendritic cell activation
|
Mesa, Circe
|
|
2006
|
24 |
S2 |
p. S42-S43
2 p.
|
artikel
|
| 43 |
Zonula occludens toxin as a new promising adjuvant for mucosal vaccines
|
Magistris, Maria Teresa De
|
|
2006
|
24 |
S2 |
p. S60-S61
2 p.
|
artikel
|
Tijdschrift beschrijving